Latest filing published 06 Jul 2020 for Ionis Pharmaceuticals INC.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -67.8%Entry US$312.50 · Close at T+365 US$100.50
- +166.2%Entry US$199.50 · Close at T+365 US$531.00
- +154.6%Entry US$188.50 · Close at T+365 US$480.00
- +35.9%Entry US$377.00 · Close at T+365 US$512.50
- -12.8%Entry US$237.50 · Close at T+365 US$207.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Breaux Castleman: trading record in brief
Filings by Breaux Castleman span 3 companies, the busiest being Ionis Pharmaceuticals Inc, USMD Holdings, Inc. and STRATA Skin Sciences, Inc. Over a trading history stretching from 14 November 2007 to 6 July 2020, the count stands at 44 filings.
On the open market, the record shows 6 purchases worth €42k and 1 sale worth €535k. The net balance comes to €493k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 10 share grants and 23 option exercises. So far in 2020, the count stands at no purchases and 1 sale.
The median purchase comes to €6,168. Looking at 6 purchases old enough to measure, the stock rose over the following 90 days in 67% of cases; the median change was +13.1%. These figures describe past trades and do not predict future prices.
The record was last updated on 6 July 2020 with an option exercise in Ionis Pharmaceuticals Inc. The clock since the last published purchase (17 August 2010) now reads 5,927 days. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Breaux Castleman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 666 shares0Common StockSEC:0000874015-20-000096:0
- 1,778 shares0Common StockSEC:0000874015-20-000096:1
- 889 shares0Common StockSEC:0000874015-20-000096:2
- 667 shares0Common StockSEC:0000874015-20-000096:3
- 10,000 shares@ US$60.0069.2% of flowCommon StockSEC:0000874015-20-000084:1
- 10,000 shares@ US$26.6630.8% of flowCommon StockSEC:0000874015-20-000084:0
- 666 shares0Common StockSEC:0000874015-19-000112:0
- 667 shares0Common StockSEC:0000874015-19-000112:1
- 889 shares0Common StockSEC:0000874015-19-000112:2
- 667 shares0Common StockSEC:0000874015-19-000112:3
- 2,000 shares0Common StockSEC:0000874015-18-000083:0
- 667 shares0Common StockSEC:0000874015-18-000083:1
- 3,406 shares0Common StockSEC:0000874015-17-000037:0
- 14,491 sharesCommon Stock ($.01 par value)SEC:0000899243-16-030646:0
- 469 shares0Common StockSEC:0000874015-16-000128:0
- 667 shares0Common StockSEC:0000874015-16-000128:1
- 937 shares0Common StockSEC:0000874015-16-000128:2
- 667 shares0Common StockSEC:0000874015-16-000128:3
- 2,099 sharesCommon Stock ($.01 par)SEC:0000899243-16-011255:0
- 371 shares@ US$15.04Common Stock ($.01 par)SEC:0000899243-15-006588:0
- 391 shares@ US$13.74Common Stock ($.01 par)SEC:0000899243-15-006588:1
- 458 shares@ US$10.44Common Stock ($.01 par)SEC:0000899243-15-006588:2
- 1,914 shares@ US$8.48Common Stock ($.01 par)SEC:0000899243-15-006588:3
- 2,156 shares@ US$7.20Common Stock ($.01 par)SEC:0000899243-15-006588:4
- 938 shares0Common StockSEC:0000874015-15-000061:0
25 of 43 declarations